Effect of PAF Antagonist on Gentamicin Nephrotoxicity
Author Information
Author(s): A. Rodriguez-Barbero, E. Bosque, L. Rivas-Cabaero, M. Arvalo, J.M. López-Novoa
Primary Institution: Facultad de Medicina, Universidad de Salamanca, Spain
Hypothesis
Could PAF be involved in gentamicin-induced nephrotoxicity?
Conclusion
The study suggests that the PAF antagonist BN-52021 reduces the severity of nephrotoxicity caused by gentamicin in rats.
Supporting Evidence
- Gentamicin treatment led to a significant increase in plasma creatinine levels.
- BN-52021 treatment resulted in a lesser increase in plasma creatinine compared to gentamicin alone.
- Histological examination showed less severe tubular damage in BN-52021 treated rats.
Takeaway
Gentamicin can harm the kidneys, but a special treatment can help protect them.
Methodology
21 Wistar rats were divided into three groups and treated with gentamicin and/or BN-52021, with renal function assessed through plasma creatinine and creatinine clearance measurements.
Limitations
The study does not confirm the exact mechanism by which PAF contributes to nephrotoxicity.
Participant Demographics
Wistar rats weighing about 250 g.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website